2019 is on track to be a record year for biotech mergers and acquisitions. This year, Big Pharma is up against a number of roadblocks, like pricing constraints and expiring patents. These ...
Category: M&A
Experts in mergers and acquisitions are cautiously optimistic as the calendar turns to 2020. Some industries expect strong M&A activity, while others are prepared for a downturn, ...
In June 2016, voters in the UK announced a desire to leave the European Union by a margin of 1.3 million votes. More than three years later, Brexit has yet to take place — and its shadow ...
Mergers and acquisitions in Europe dipped in Q1 of 2019. The looming threat of Brexit played a major role in slowing deal activity, and anti-competition rulings added to market concerns. ...
Legal companies, whether large or small, deal with masses of documents each month. Each trial, merger and acquisition or contract involves a significant amount of paperwork and companies ...
Efficiency and accuracy of data sharing are essential attributes when it comes to certain processes in the corporate world, in particular Mergers and Acquisitions (M&A) or IPOs. Since ...
It may only be March, but 2017 has already been characterized by the M&A deals that didn’t happen. Headlines have been dominated by the highly publicized failed merger between the ...
Off the back of Amazon’s recent bid to buy out Whole Foods, the words ‘mergers and acquisitions’ or M&A are being thrown around websites like there’s no tomorrow – 30 years ago this ...
The first quarter always brings with it a slew of analyses and think pieces on every possible financial trend for the year ahead. And this year is all about much-anticipated M&A boom. ...
Acquisition is an art, and it’s an art that must be mastered if you want to see your business grow. Done well, it can add value and reach, catapulting your company to the big time. Done ...
